ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

ハロキサゾラム

Haloxazolam

HCID 3563
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
59128-97-1
標準SMILES
O=C1CN2CCOC2(c2ccccc2F)c2cc(Br)ccc2N1
InChIKey
XDKCGKQHVBOOHC-UHFFFAOYSA-N
分子式
C17H14BrFN2O2
平均分子量
377.2 g/mol
単同位体質量
376.02227

概要

Haloxazolam is an organic molecular entity.

名称と識別子

優先名称
Haloxazolam
IUPAC
10-bromo-11b-(2-fluorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
現地名
ハロキサゾラム
英語名
Haloxazolam
分子式
C17H14BrFN2O2
分子量
377.21

名称と別名

haloxazolamSomelin59128-97-1HaloxazolamumCS-430M448L2V8XP10-Bromo-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-oneDTXSID6086674010-Bromo-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d](1,4)benzodiazepin-6(5H)-oneRefChem:783374DTXCID90814996(11bRS)-10-Bromo-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydro(1,3)oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one
名称をさらに表示
ハロキサゾラムソメリン10-ブロモ-11b-(o-フルオロフェニル)-2,3,7,11b-テトラヒドロオキサゾロ[3,2-d][1,4]ベンゾジアゼピン-6(5H)-オン10-ブロモ-11b-(2-フルオロフェニル)-2,3,7,11b-テトラヒドロオキサゾロ[3,2-d][1,4]ベンゾジアゼピン-6(5H)-オンハロキサゾラム (JP17)13-ブロモ-2-(2-フルオロフェニル)-3-オキサ-6,9-ジアザトリシクロ[8.4.0.02,6]テトラデカ-1(14),10,12-トリエン-8-オンNot foundHaloxazo1amBrn 0569670Dea no. 2771azepin-6(5h)-one2-fluorophenyl)-
13-bromo-2-(2-fluorophenyl)-3-oxa-6,9-diazatricyclo(8.4.0.02,?)tetradeca-1(10),11,13-trien-8-one13-bromo-2-(2-fluorophenyl)-3-oxa-6,9-diazatricyclo(8.4.0.02,6)tetradeca-1(10),11,13-trien-8-one10-bromo-11b-(2-fluorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one10-Bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-oneHaloxazolam [INN:JAN]Haloxazolam (1.0mg/ml in Acetonitrile)10-Bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-oneOxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one, 2,3,7,11b-tetrahydro-10-bromo-11b-(2-fluorophenyl)-

物性

構造計算による物性

XLogP
2.8
極性表面積
41.6 Ų
水素結合供与体数
1
水素結合受容体数
4
回転可能結合数
1
重原子数
23
形式電荷
0
複雑度
480

実験および物理化学的性質

Drugs · 3 件

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Nervous system -> Anxiolytics

物理化学的性質

融点
185 ° · 185°
沸点
204 °C · 204°C (rough estimate)
比重(密度)
1.4808 · 1.4808 (estimate)
酸解離定数(Pka)
12.66 · 12.66±0.40(Predicted)
NISTの化学物質情報
Haloxazolam(59128-97-1)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Regulatory InformationDEA schedule IV controlled substance

毒性情報

Treatment · 1 件

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Toxicity Summary · 1 件

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

化学と産業

用途と製造

UsesHaloxazolam is indicated for the treatment insomnia.

応用分野

用途習慣性医薬品

使用Sleep-inducing agent, related structurally to Oxazolam and Cloxazolam (C587475). Sedative, hypnotic. Controlled substance (depressant).

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
59128-97-1
PubChem CID
3563
DTXSID
DTXSID60866740
ChEMBL
CHEMBL2104461
ChEBI
CHEBI:31666
UNII
M448L2V8XP
Nikkaji
J3.200J

安全データ

ridadr
3249
毒性
LD50 in mice: 1850 mg/kg orally (Kamioka)
hazard_class
6.1(b)
packing_group
III
DEA Controlled Substances
CSCN: 2771CSA SCH: Schedule IVNARC: No